Bulking Agents (Microcystalline Cellulose, Dicalcium Phosphate), L-Glutathione, Anti-caking Agents (Silicon Dioxide, Magnesium Stearate), Biotin, Copper Sulphate
Reporting indicated that there was not enough interest among Part D plans to launch the model as designed
Ultimately, shared decision-making between clinicians and patients should weigh clinical effectiveness, side effect profiles, lifestyle compatibility, and financial considerations to determine the most appropriate semaglutide formulation for each individual's circumstances
Methods This was a retrospective study among adult patients with T2DM with 1 claim for oral semaglutide between November 1, 2019`1June 30, 2020